Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/163222
Title: Degradable mesoporous semimetal antimony nanospheres for near-infrared II multimodal theranostics
Authors: Chen, Yu
Yu, Zhongzheng
Zheng, Kai
Ren, Yaguang
Wang, Meng
Wu, Qiang
Zhou, Feifan
Liu, Chengbo
Liu, Liwei
Song, Jun
Qu, Junle
Keywords: Engineering::Bioengineering
Issue Date: 2022
Source: Chen, Y., Yu, Z., Zheng, K., Ren, Y., Wang, M., Wu, Q., Zhou, F., Liu, C., Liu, L., Song, J. & Qu, J. (2022). Degradable mesoporous semimetal antimony nanospheres for near-infrared II multimodal theranostics. Nature Communications, 13(1), 539-. https://dx.doi.org/10.1038/s41467-021-27835-y
Journal: Nature Communications 
Abstract: Metallic and semimetallic mesoporous frameworks are of great importance owing to their unique properties and broad applications. However, semimetallic mesoporous structures cannot be obtained by the traditional template-mediated strategies due to the inevitable hydrolytic reaction of semimetal compounds. Therefore, it is yet challenging to fabricate mesoporous semimetal nanostructures, not even mention controlling their pore sizes. Here we develop a facile and robust selective etching route to synthesize monodispersed mesoporous antimony nanospheres (MSbNSs). The pore sizes of MSbNSs are tunable by carefully controlling the partial oxidation of Sb nuclei and the selective etching of the as-formed Sb2O3. MSbNSs show a wide absorption from visible to second near-infrared (NIR-II) region. Moreover, PEGylated MSbNSs are degradable and the degradation mechanism is further explained. The NIR-II photothermal performance of MSbNSs is promising with a high photothermal conversion efficiency of ~44% and intensive NIR-II photoacoustic signal. MSbNSs show potential as multifunctional nanomedicines for NIR-II photoacoustic imaging guided synergistic photothermal/chemo therapy in vivo. Our selective etching process would contribute to the development of various semimetallic mesoporous structures and efficient multimodal nanoplatforms for theranostics.
URI: https://hdl.handle.net/10356/163222
ISSN: 2041-1723
DOI: 10.1038/s41467-021-27835-y
Rights: © The Author(s) 2022. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SCBE Journal Articles

Files in This Item:
File Description SizeFormat 
s41467-021-27835-y.pdf3.14 MBAdobe PDFView/Open

SCOPUSTM   
Citations 50

6
Updated on Jan 31, 2023

Web of ScienceTM
Citations 50

5
Updated on Jan 31, 2023

Page view(s)

15
Updated on Feb 5, 2023

Download(s)

3
Updated on Feb 5, 2023

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.